Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GMED · against 157 other Healthcare companies of similar size
Ranked #42 of 158 · scores higher than 74% of peers · safety percentile 67
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)11 peers with a safety percentile of 60–69, including GMED · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 152 reported | 0.02× | 0.35× | 86% | 33% | |
| BetaLower is better · 160 reported | 0.96 | 0.58 | 25% | 33% | |
| Current ratioHigher is better · 149 reported | 4.62× | 2.30× | 78% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 5.7B USD | 97 | 52 | |
| 38 | 521.3B INR (≈$6.3B) | 69 | 69 | |
| 39 | 13.9B EUR (≈$15.3B) | 69 | 78 | |
| 40 | 921.9B INR (≈$11.1B) | 68 | 82 | |
| 41 | 138.4B HKD (≈$17.7B) | 68 | 70 | |
| 42 | 10.7B USD | 67 | 78 | |
| 43 | 9.0B USD | 67 | 33 | |
| 44 | 871.6B INR (≈$10.5B) | 66 | 66 | |
| 45 | 9.3B AUD (≈$6.1B) | 66 | 55 | |
| 46 | 1.03T JPY (≈$7.0B) | 66 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score